Startup profile for Function Health: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.
Venture Capital Tracker logo
Venture Capital Tracker

Startup profile · funding coverage

Function Health funding, valuation and investors

Membership-based preventive health platform offering comprehensive lab testing and medical intelligence.

Keep track of Function Health

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series B

$298M · 2025

Latest known valuation

$2.5B

Series B · 2025

Total disclosed equity funding

$351M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

series b

Investors in latest funding

Lead: Redpoint Ventures

Other: Andreessen Horowitz , Battery Ventures , Menlo Ventures , FirstMark Capital

Sources: latest funding Last verified: 2026-07-25

Overview

Function Health is a membership-based preventive health platform that offers comprehensive lab panels, biomarker tracking, and clinician-reviewed insights — targeting consumers who want proactive health data beyond annual physicals.

Why Function Health is interesting

Function Health hit a $2.5B valuation on rapid consumer lab-testing growth; a16z backed from Series A with Redpoint leading the 2025 Series B.

Product & use cases

Membership-based preventive health platform with comprehensive lab testing, biomarker tracking, and clinician-reviewed insights.

  • Comprehensive lab panels beyond annual physicals
  • Longitudinal biomarker tracking over time
  • Preventive health data for proactive consumers

Key facts

  • Series B (2025): $298M led by Redpoint Ventures (/fund/redpoint-ventures) with a16z (/fund/andreessen-horowitz), Battery Ventures (/fund/battery-ventures), and Menlo Ventures (/fund/menlo-ventures) (TechCrunch)
  • Series A (2024): $53M led by a16z (company announcement); reported $2.5B valuation at Series B

Funding history (newest first)

Series B

2025 $298M Valuation: $2.5B

Source: https://techcrunch.com/2025/06/10/function-health-raises-298m/

Series A

2024 $53M

Source: https://www.functionhealth.com/blog/series-a

Investors in our directory

Funds linked from Function Health's profile — open a fund page for stage focus and related deal articles.

Andreessen Horowitz Battery Ventures FirstMark Capital Menlo Ventures Redpoint Ventures

Competitive landscape

Edge: Broad lab panels with longitudinal tracking at consumer scale — $298M Series B at $2.5B with Redpoint, a16z, Battery, and Menlo.

Direct-to-consumer lab testing is accelerating. Function Health's $298M Series B (2025) at $2.5B validates demand for proactive health data outside insurance workflows — a16z led Series A ($53M, 2024).

  • InsideTracker direct

    Consumer biomarker tracking; Function offers broader panels.

  • Quest/LabCorp direct incumbent

    Direct lab ordering; Function adds interpretation layer.

  • One Medical (Amazon) adjacent

    Primary care; Function is lab-focused preventive.

Notable stories

  • Function Health reached $2.5B valuation within roughly a year of its Series A — one of the fastest consumer health scaling stories (TechCrunch, 2025).

Industries

Healthtech Consumer

FAQs about Function Health

Practical answers founders, operators, and investors typically search for.

Function Health offers a membership-based preventive health service with comprehensive lab testing, biomarker tracking over time, and clinician-reviewed insights — aimed at consumers seeking proactive health data.
Function Health's $298M Series B (2025) was led by Redpoint Ventures (/fund/redpoint-ventures) with Andreessen Horowitz (/fund/andreessen-horowitz), Battery Ventures (/fund/battery-ventures), and Menlo Ventures (/fund/menlo-ventures). a16z led the prior $53M Series A (2024).
Function Health is at Series B based on its 2025 $298M round at a reported $2.5B valuation.
Direct-to-consumer lab testing is accelerating as consumers demand more health data. Function bundles broad panels with longitudinal tracking — a wedge into preventive care outside traditional insurance workflows.
No. Function Health remains a private company.
Function offers 100+ biomarkers vs typical 20-30 in standard physicals, with longitudinal tracking.
Membership-based pricing — see functionhealth.com for current rates.
$2.5B at Series B (2025) per TechCrunch.
All startups Funding news

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.